Abstract

The provision of antipsychotics can cause poot response and side effects such symptoms of extrapyramidal metabolic syndrome. Extrampyramidal side effects are one of the causes of patients become frequent relapses and treatment will be even longer and can last a lifetime. Objective know the description of the characteristics on the patients with extrapyramidal syndrome. This research uses non-experimental research and descriptive research type. The sample is 30 patients with total sampling. The instrument with questionnaire sheets. Univariate analysis with descriptive frequencies was used to analyze the data obtained. Result the most respondents, 13 respondents (43,3%), had extrapyramidal syndromes, 13 respondents (43,3%) were aged 17-25 years old, 21 respondents (70,0%) were male, 10 respondents (33,3%) were graduates from junior high school. Most patients 11 respondents (36,7%), received the therapy for chlorpromazine + tribexyphenidyl + haloperidol, 13 respondents (43,3%) received the therapy for schizoaffective medical diagnoses, 17 respondents (56,7%) had a history of irregular therapy, 26 respondents (86,7%) did not have history of comorbidities and 12 respondents (40,0%) had a history of early mental illness for the first time. Most EPS patients got chlorpromazine, had a history of irregular therapy, had no history of comorbidities and had a history of early mental disorder for first time.
 
 Keywords: extrapyramidal syndrome

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call